Literature DB >> 15780053

Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease.

Michel Henry Mendler1, Gary Kanel, Sugantha Govindarajan.   

Abstract

AIM/
BACKGROUND: The spectrum of histopathological features in non-alcoholic fatty liver disease (NAFLD) has been well described. At least two scoring systems have been established. We propose here a system in which numerical scores are obtained using the different features.
METHODS: Twenty-five cases of well-defined NAFLD were identified. Two pathologists blinded to identifiers and clinical data independently scored the liver biopsies twice for portal fibrosis (PF: 0-6), lobular inflammation and necrosis (LIN: 0-3), Mallory bodies (MB: 0-3), hepatocyte ballooning (HB: 0-3), perisinusoidal fibrosis (PSF: 0-3) and fatty change (FC: 1-4). The kappa statistic tested observer concordance. Non-parametric measures of correlation and hierarchical cluster analysis were used to elaborate a grading system.
RESULTS: A broad spectrum of NAFLD was observed. Intra- and interobserver concordance was satisfactory. An activity score was created (AS: 0-12) as the sum of LIN, MB, HB and PSF, but not FC. A system for severity of NAFLD was developed: Grade 1 (PF: 0-2 and AS: 0-4), Grade 2 (PF: 3 or AS: 5-7) and Grade 3 (PF: 4-6 or AS: 8-12). Diabetes, elevated alkaline phosphatase and decreased platelets were associated with advanced grade.
CONCLUSIONS: This simple, reproducible NAFLD score produces a three-tier severity grade. This numerical system may prove useful in assessing disease severity and interval changes. Copyright Blackwell Munksgaard 2005

Entities:  

Mesh:

Year:  2005        PMID: 15780053     DOI: 10.1111/j.1478-3231.2005.01052.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  16 in total

Review 1.  Histopathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

Review 2.  Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease.

Authors:  Andrea Tannapfel; Helmut Denk; Hans-Peter Dienes; Cord Langner; Peter Schirmacher; Michael Trauner; Berenike Flott-Rahmel
Journal:  Virchows Arch       Date:  2011-03-26       Impact factor: 4.064

Review 3.  The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.

Authors:  Mangesh R Pagadala; Arthur J McCullough
Journal:  Clin Liver Dis       Date:  2012-06-27       Impact factor: 6.126

4.  Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity.

Authors:  Charles H C Pilgrim; Laveniya Satgunaseelan; Alan Pham; William Murray; Emma Link; Marty Smith; Val Usatoff; Peter M Evans; Simon Banting; Benjamin N Thomson; Wayne A Phillips; Michael Michael
Journal:  HPB (Oxford)       Date:  2012-03-26       Impact factor: 3.647

5.  mRNA gene expression correlates with histologically diagnosed chemotherapy-induced hepatic injury.

Authors:  Charles H C Pilgrim; Kate Brettingham-Moore; Alan Pham; William Murray; Emma Link; Marty Smith; Val Usatoff; Peter M Evans; Simon Banting; Benjamin N Thomson; Michael Michael; Wayne A Phillips
Journal:  HPB (Oxford)       Date:  2011-08-02       Impact factor: 3.647

6.  Pathological study of 130 cases of nonalcoholic fatty liver disease based on NASH-CRN system.

Authors:  Guangde Zhou; Jingmin Zhao; Xiaohui Ding; Deng Pan; Yanling Sun; Jianfa Yang; Yulai Zhao
Journal:  Front Med China       Date:  2007-10

7.  High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model.

Authors:  Michael Nathan VanSaun; In Kyu Lee; Mary Kay Washington; Lynn Matrisian; David Lee Gorden
Journal:  Am J Pathol       Date:  2009-06-18       Impact factor: 4.307

Review 8.  [Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Grade 2 consensus-based guidelines].

Authors:  A Tannapfel; H Denk; H P Dienes; C Langner; P Schirmacher; M Trauner; B Flott-Rahmel
Journal:  Pathologe       Date:  2010-05       Impact factor: 1.011

9.  Hepcidin expression in iron overload diseases is variably modulated by circulating factors.

Authors:  Giulia Ravasi; Sara Pelucchi; Paola Trombini; Raffaella Mariani; Naohisa Tomosugi; Giulia Litta Modignani; Matteo Pozzi; Elizabeth Nemeth; Tomas Ganz; Hisao Hayashi; Donatella Barisani; Alberto Piperno
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

10.  Treatment of non-alcoholic fatty liver disease.

Authors:  Keith G Tolman; Anthony S Dalpiaz
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.